AMICOSANTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 30.436
EU - Europa 3.019
AS - Asia 2.922
SA - Sud America 405
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 37
OC - Oceania 8
Totale 36.924
Nazione #
US - Stati Uniti d'America 30.346
SG - Singapore 1.468
DE - Germania 1.077
CN - Cina 691
UA - Ucraina 394
BR - Brasile 331
RU - Federazione Russa 293
IT - Italia 272
IE - Irlanda 254
HK - Hong Kong 226
FR - Francia 225
VN - Vietnam 223
SE - Svezia 123
GB - Regno Unito 115
FI - Finlandia 111
KR - Corea 86
JP - Giappone 53
CA - Canada 48
IN - India 41
PL - Polonia 40
BD - Bangladesh 37
AR - Argentina 29
RO - Romania 27
BE - Belgio 16
ZA - Sudafrica 16
EC - Ecuador 15
AT - Austria 13
MX - Messico 13
BG - Bulgaria 11
CO - Colombia 11
ES - Italia 11
ID - Indonesia 11
IQ - Iraq 11
NL - Olanda 10
KG - Kirghizistan 9
TR - Turchia 9
CL - Cile 8
EU - Europa 8
JM - Giamaica 8
IL - Israele 7
TH - Thailandia 7
UZ - Uzbekistan 7
AU - Australia 6
MY - Malesia 5
PE - Perù 5
EG - Egitto 4
KE - Kenya 4
PH - Filippine 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
BS - Bahamas 3
CH - Svizzera 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
PR - Porto Rico 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SI - Slovenia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TL - Timor Orientale 1
Totale 36.834
Città #
Woodbridge 9.446
Wilmington 7.870
Houston 7.305
Ann Arbor 714
Fairfield 655
Singapore 632
Ashburn 442
Jacksonville 376
Beijing 305
Chandler 302
San Jose 290
Seattle 282
Dublin 244
Hong Kong 221
Cambridge 219
Medford 187
Dearborn 152
New York 117
Council Bluffs 110
Santa Clara 97
Lawrence 87
The Dalles 70
Ho Chi Minh City 69
Los Angeles 67
Rome 67
Menlo Park 63
Hanoi 58
Dallas 56
Lauterbourg 55
Zhengzhou 53
Tokyo 42
Buffalo 40
Guangzhou 37
Milan 37
Mülheim 27
San Diego 27
Kraków 25
São Paulo 25
Helsinki 23
Norwalk 20
Redondo Beach 20
Chicago 19
Moscow 19
Shanghai 18
Nanjing 17
Boardman 16
London 15
Munich 15
Brussels 14
Denver 14
Falls Church 14
Mountain View 14
Rio de Janeiro 14
Hefei 13
Orem 13
Palo Alto 13
Nuremberg 12
University Park 12
Verona 12
Warsaw 12
Atlanta 11
Frankfurt am Main 11
Montreal 11
San Francisco 11
San Mateo 11
Toronto 11
Columbus 10
Johannesburg 10
Stockholm 10
Chennai 9
Redwood City 9
Sofia 9
Belo Horizonte 8
Da Nang 8
North Bergen 8
Detroit 7
Haiphong 7
Mcallen 7
Mumbai 7
Nanchang 7
Phoenix 7
Quito 7
Boston 6
Campinas 6
Las Vegas 6
Melbourne 6
Philadelphia 6
Porto Alegre 6
Pune 6
Tashkent 6
Vienna 6
Auburn Hills 5
Brasília 5
Brooklyn 5
Cape Town 5
Fortaleza 5
Fuzhou 5
Guayaquil 5
Hangzhou 5
Indiana 5
Totale 31.505
Nome #
Role of individual's T cell immunome in controlling HIV-1 progression 609
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay 604
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 559
B-Pred, a structure based B-cell epitopes prediction server 542
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations 527
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model 522
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 509
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 496
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 492
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 490
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 488
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy 484
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 480
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 468
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 467
An outbreak of Q fever in Bulgaria 466
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 461
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 456
Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 epidemic 454
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 453
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 447
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins 447
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 446
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study 443
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 442
Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption 441
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. 441
Key role of human leukocyte antigen in modulating HIV progression: an overview of the possible applications. 438
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 437
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 436
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 435
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients 433
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis 432
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy 432
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport 431
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 430
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins 428
Dynamics of the laboratory results in patients with pulmonary tuberculosis. 427
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction 427
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 427
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection 425
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 423
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 422
Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis 420
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 418
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 417
Beryllium disease 415
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity 414
Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis 411
IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor? 404
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 404
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 404
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 403
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 403
Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis 400
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis 399
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 398
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 393
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 392
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 392
Metal-induced diffuse lung disease 389
[Mycobacterium tuberculosis. From the gene to the diagnosis] 386
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 385
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 384
[Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value] 384
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 383
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis 382
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 381
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 380
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 380
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding 379
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 376
Major histocompatibility locus genetic markers of beryllium sensitization and disease 373
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 373
Seroprevalence of Ebola virus infection in Bombali district, Sierra Leone 372
Rapid immunological test for the diagnosis and monitoring of tuberculosis infection. 365
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 363
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 361
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 351
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 351
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 345
T cell recognition in chronic beryllium disease 345
Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. 341
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 321
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 319
Metodo e test diagnostici basati sull’analisi citofluorimetrica dei linfociti T antigene-specifici. 279
Occurrence of Legionella in showers at recreational facilities 210
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns 153
Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial 135
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 74
Totale 36.924
Categoria #
all - tutte 75.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 82 22 59 21 92 43 40 52 59 65 225
2022/2023867 104 55 29 104 67 242 91 40 71 1 43 20
2023/2024289 47 6 16 12 17 101 7 2 21 4 2 54
2024/20252.043 80 424 214 91 40 75 153 101 202 149 279 235
2025/20262.863 247 174 385 275 240 95 287 346 403 237 86 88
2026/2027277 147 130 0 0 0 0 0 0 0 0 0 0
Totale 36.924